S&P Global Inc/ US78409V1044 /
31/05/2024 22:10:00 | Var. +5.92 | Volume | Denaro01:37:30 | Lettera01:37:30 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
427.51USD | +1.40% | 1.85 mill. Fatturato: 405.35 mill. |
426.51Quantità in denaro: 100 | 440.00Quantità in lettera: 100 | 133.77 bill.USD | 0.84% | 51.82 |
GlobeNewswire
23:07
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
18:30
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
17:31
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
GlobeNewswire
16:55
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Ear...
GlobeNewswire
16:00
Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Acro...
GlobeNewswire
16:00
ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1...
GlobeNewswire
16:00
Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT...
GlobeNewswire
15:51
BIIB INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with Sub...
GlobeNewswire
15:01
Celldex Therapeutics Presents Data Demonstrating Profound Improvements in Angioedema in Barzolvolima...
GlobeNewswire
14:56
NVIDIA Enables Real-Time Healthcare, Industrial and Scientific AI Applications at the Edge With Ente...
GlobeNewswire
14:52
NVIDIA Robotics Adopted by Industry Leaders for Development of Tens of Millions of AI-Powered Autono...